Home > Clinical Trials

Saved trials

TERMINATED
NCT04593784
Study of Ciraparantag for Reversal of Anticoagulation Induced by Edoxaban, Apixaban or Rivaroxaban in Healthy Adults
41 Enrollment(s)
3 Study location(s)
INTERVENTIONAL (PHASE2)
Healthy
NOT_YET_RECRUITING
NCT06912763
Reversing External-beam Radiotherapy-associated Fibrosis Syndrome: an Interventional Bayesian Adaptive Randomized-controlled Orphan Drug Platform Trial for Orodental Sequelae (Reverse-fibrose)
250 Enrollment(s)
1 Study location(s)
INTERVENTIONAL (PHASE2)
Fibrosis Syndrome


Lymphedema


Head &Amp; Neck Cancer


Fibrosis
RECRUITING
NCT06467357
Phase 3 Study of T-DXd and Rilvegostomig Versus SoC in Advanced HER2-expressing Biliary Tract Cancer
620 Enrollment(s)
222 Study location(s)
INTERVENTIONAL (PHASE3)
Biliary Tract Cancer
ACTIVE_NOT_RECRUITING
NCT06449469
The Nordic Aortic Valve Intervention Trial 4 (NOTION-4)
352 Enrollment(s)
2 Study location(s)
INTERVENTIONAL (NA)
Aortic Valve Stenosis


Cardiovascular Diseases


Heart Diseases


Heart Valve Diseases


Valve Disease, Aortic
RECRUITING
NCT06429761
Phase 4 Study to Assess the Safety of Trastuzumab Deruxtecan, in Indian Patients
100 Enrollment(s)
4 Study location(s)
INTERVENTIONAL (PHASE4)
BREAST CANCER
RECRUITING
NCT05993234
A Study of Trastuzumab DeRuxtecan for Patients With Advanced HER2-pOsitive GaStric or GastroesoPhageal Junction AdEnocarcinoma Who Have Received a PrIor Trastuzumab-based Regimen Accompanied by a Disease RegistrY of Patients Treated With Conventional Therapies (PROSPERITY)
257 Enrollment(s)
68 Study location(s)
OBSERVATIONAL (None)
HER2-positive Advanced Gastric Cancer


HER2-positive Gastroesophageal Junction Adenocarcinoma
RECRUITING
NCT05945732
DESTINY Breast Respond HER2-low Europe
1,350 Enrollment(s)
198 Study location(s)
OBSERVATIONAL (None)
Unresectable Breast Cancer


Metastatic Breast Cancer


HER2-low Expressing Breast Cancer
COMPLETED
NCT03488420
Canadian EdoxAban(Lixiana®) Registry in Patients With ATrial Fibrillation/Flutter With Confirmed ValvUlar HeaRt DiseasE
136 Enrollment(s)
9 Study location(s)
OBSERVATIONAL (None)
Atrial Fibrillation and Flutter


Valvular Heart Disease